One Regeneron drug, billions in sales, millions in salaries

That's the sales revenue for blockbuster eye drug Eylea in 2018, according Regeneron's annual report, released earlier this year. We've written plenty over the years about the manufacturer's growth from a few hundred people in Rensselaer County to more than 2,600 — with more on the way. Eylea, used to treat macular degeneration, has become the company's flagship product, and is one of the best-selling drugs in the world. A list produced by industry publication Genetic Engineering& Biotechnology …
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news